Gilead Sciences, Inc.GILDNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank86
3Y CAGR+0.2%
5Y CAGR+2.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+0.2%/yr
vs +8.7%/yr prior
5Y CAGR
+2.2%/yr
Consistent
Acceleration
-8.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.71B | -6.3% |
| 2024 | $6.09B | +0.0% |
| 2023 | $6.09B | +7.4% |
| 2022 | $5.67B | +8.1% |
| 2021 | $5.25B | +2.6% |
| 2020 | $5.11B | +16.7% |
| 2019 | $4.38B | +8.0% |
| 2018 | $4.06B | +4.6% |
| 2017 | $3.88B | +14.1% |
| 2016 | $3.40B | - |